Evaluation of tumor targets selected from public genomic databases for imaging of pancreatic ductal adenocarcinoma

Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a 5-year survival rate of approximately 5–7%, and complete surgical resection remains the only curative treatment but is often unfeasible. Fluorescence-guided surgery (FGS) using tumor-targeted probes may improve tumor...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Nada Badr, Luca Ten Elshof, Ruben D. Houvast, Lysanne D. A. N. de Muynck, A. Stijn L. P. Crobach, Gerard J. P. van Westen, Ronald L. P. van Vlierberghe, J. Sven D. Mieog, Alexander L. Vahrmeijer, Peter J. K. Kuppen
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-05-01
Subjects:	Pancreatic cancer Tumor-target selection Fluorescence-guided surgery Data-driven approach Molecular imaging
Online Access:	https://doi.org/10.1038/s41598-025-00517-1